reported that AAV expression of INSR-A or INSR-B significantly reduced the NAFLD activity score (NAS) and improved insulin secretion, but did not affect body weight or glucose tolerance in mice on a high fat diet (131). Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.